Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.

about

Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.

Item

http://www.wikidata.org/entity/Q48377661

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@en

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@nl

type

Item

label

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@en

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@nl

prefLabel

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@en

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@nl

P1476

Evaluation of hormonal suppres ...... nyl estradiol and desogestrel.

@en

P2093

Danitza Thomazi Gassen

http://www.w3.org/2001/XMLSchema#string

Helena Schmid

http://www.w3.org/2001/XMLSchema#string

Juliana Kliemann Chagas

http://www.w3.org/2001/XMLSchema#string

Liliane Diefenthaeler Herter

http://www.w3.org/2001/XMLSchema#string

P2860

Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms.

Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.

Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms.

Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder.

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.

Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.

Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.

Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins.

Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.

P2888

s00404-012-2545-6

P304

289-294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00404-012-2545-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22976131

http://www.w3.org/2001/XMLSchema#string